Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

62.04
+2.303.85%
Post-market: 62.120.0815+0.13%19:30 EDT
Volume:2.21M
Turnover:135.49M
Market Cap:10.31B
PE:-17.83
High:62.07
Open:60.54
Low:59.70
Close:59.74
52wk High:86.74
52wk Low:41.71
Shares:166.18M
Float Shares:161.92M
Volume Ratio:0.84
T/O Rate:1.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:23.45
PE(LYR):-26.05

Loading ...

Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 07, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2022

Major Issues Report

8-K - Current report